₹24.95 Crores | Listing at BSE | Mon, Jul 17, 2023 - Wed, Jul 26, 2023
Eiko Lifesciences Limited Rights Issue comprises 0.5544 Cr equity shares aggregating to ₹24.95 Cr, offered at an issue price of ₹45 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Jul 7, 2023, with the Rights Issue being offered in the entitlement ratio of 2 : 3.
The term of payment is defined as following : The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board.
The Rights Entitlements are expected to be credited to eligible demat accounts on Aug 3, 2023.
The Rights Issue opens on Jul 17, 2023, and closes on Jul 26, 2023, with renunciation of Rights Entitlements permitted up to Jul 20, 2023.
The deemed date of allotment is Aug 3, 2023, following which the equity shares are expected to be credited to demat accounts on Aug 4, 2023 and listed at the BSE on Aug 10, 2023.
PNB Investment Services Ltd. is the Lead Manager to the issue and Bigshare Services Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Eiko Lifesciences Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Fri, Jul 7, 2023
Entitlement Ratio
2 : 3
Open Date
Mon, Jul 17, 2023
Close Date
Wed, Jul 26, 2023
The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board.
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 16.61 | 12.45 | 0.61 |
| 31-Mar-22 | 34.89 | 26.09 | 0.71 |
| Amount in ₹ Crore | |||
Incorporated in 1977, Eiko LifeSciences Limited is engaged in the manufacturing, supplying, and export business of Speciality Chemicals and Pharma Intermediates. The company supplies its offerings in India and worldwide.
The products of the company are used in segments like Pharmaceuticals, Agrochemicals, Aroma Chemicals, Electronic Chemicals, and others.
Eiko LifeSciences established a manufacturing unit at MIDC, Badlapur, and has also tied up with many job-workers for manufacturing.
The Company proposes to utilize the net proceeds from the Issue towards funding the following objects:
[Dilip Davda] The company is in the business of various chemicals and pharma ingredients products manufacturing. Its financial performance so far has been average. Perhaps, promoter’s holding marked rise amidst market operations to pave the way for pricey RI. The issue appears greedily priced. There is no harm in skipping this RI. Read detail review...
Eiko Lifesciences Limited
604, Centrum, Opp. TMC Office,
Near Satkar Grande Hotel, Wagle Estate,
Thane - 400604
Thane, Maharashtra, 400604
The Eiko Lifesciences Rights Issue 2023 opens on Mon, Jul 17, 2023, and closes on Wed, Jul 26, 2023.
Eiko Lifesciences Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | Wed, Jul 12, 2023 |
| Last Date for renunciation of Rights Entitlements | Thu, Jul 20, 2023 |
| Issue Opening Date | Mon, Jul 17, 2023 |
| Issue Closing Date | Wed, Jul 26, 2023 |
| Date of Allotment (on or about) | Thu, Aug 3, 2023 |
| Date of Credit (on or about) | Fri, Aug 4, 2023 |
| Date of Listing (on or about) | Thu, Aug 10, 2023 |
You can apply for Eiko Lifesciences Rights Issue 2023 in two ways:
Steps to apply for Eiko Lifesciences Rights Issue 2023 using Net Banking (ASBA)
Steps to apply for Eiko Lifesciences Rights Issue 2023 using Registrar's website (R-WAP)
